Skip to content

Shrungyadi Churna and Dhumapana in the management of Tamaka Shwasa w.s.r to Bronchial Asthma

Role of Shrungyadi Churna orally along with Dhumapana in Tamaka Shwasa w.s.r to Bronchial Asthma - An open labelled clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082457
Enrollment
30
Registered
2025-03-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00-J99- Diseases of the respiratory system

Interventions

None listed

Sponsors

Government Akhandanand Ayurveda College Ahmedabad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Both male & female Patients having age between 18 to 60 years of age. Patients with classical signs and symptoms of Tamaka Shwasa described in ancient Ayurveda text. ShwasaKrichchhata (Dyspnoea) Ghurghurukama (Wheezing sound) Kasa (Cough) Asamyakanidra (Disturbed sleep) Kantodhwamsa (Hoarseness of voice) Pinasa (Rhinitis) ShleshmaVimokshanteMuhurtamSukham (After expectoration patient feels better) ParshvaAvgrihyate (Chest tightness) PEF (Peak Expiratory Flow Rate): 50 to 100%

Exclusion criteria

Exclusion criteria: Patients below 18 years and above 60 years. Patients suffering from the systemic or serious illness like Emphysema, diabetes mellitus, hypertension, Renal diseases and cardiac diseases. Patients of Cor pulmonale, Cardiac Asthma and severe exacerbation. Any acute systemic disease or Infection, with post covid lung disease or complication. Pregnant and lactating mothers. Any malignancy, TB. Acute & serious conditions require immediate intervention will be excluded. Patients described as Dhumapana Ayogya in classical text. PEF below 50%

Design outcomes

Primary

MeasureTime frame
Results will be assessed on the basis of gradation of clinical features of Tamaka ShwasaTimepoint: Follow up will be done for 2 weeks after completion of treatment

Secondary

MeasureTime frame
Peak flow meter reading to access improvement of lung functionsTimepoint: Follow up study will be done for the period of 2 weeks after completion of treatment

Countries

India

Contacts

Public ContactYogina Rathwa

Government Akhandanand Ayurved College and Hospital, Ahmedabad

ayursoni@yahoo.com8209199183

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026